Study to Evaluate the Efficacy and Safety of a new medication in Adults with Moderate-to-Severe Atopic Dermatitis.
The study will last aproximately 5 months, including up to 10 clinic visits.
Criteria:Be 18 years of age or older,
Have been diagnosed with Atopic Dermatitis/Eczema for at least 1 year
Have used topical treatments that have not entirely controlled the disease